Some patients with hypoplastic marrow disorders, including aplastic anemia (AA), are at risk for clonal evolution to myelodysplastic syndromes (MDS) and leukemia. Magnetic resonance imaging (MRI) of marrow of the spine, pelvis, and femurs was performed in 24 patients with hypoplastic marrow disorders. In 12 patients (three AA, nine MDS) MRI was compatible with the clinical and biopsy diagnoses and served to define the spectrum of marrow patterns in these disorders. In eight patients with hypocellular marrow biopsies and a clinical diagnosis of AA, MRI showed an unexpected inhomogeneous or diffuse cellular pattern. Concurrent or YPOPLASTIC BONE marrow disorders result in H cytopenias affecting red blood cells (RBCs), granulocytes, and platelets. Primary disorders include aplastic anemia (AA), myelodysplastic syndromes (MDS), and myelofibrosis (MF). Secondary disorders result from extensive marrow infiltration by cancer or lymphoma or from toxic effects of chemotherapy or radiotherapy. Severe AA, as defined by the International Aplastic Anemia Study Group (IAASG),' has a hypocellular, fatty marrow. MDS, as defined by the French-American-British (FAB) classification,2 has a cellular or hypercellular marrow, frequent cytogenetic abn~rmalities,~.~ and known risk of evolution to acute myelogenous leukemia (AML).9
subsequent marrow or cytogenetic studies have led to diagnoses of hypoplastic MDS in seven of these patients. In four patients with prolonged hypoplasia after bone marrow transplantation for lymphoma, a speckled pattern superimposed on a fatty background appeared in serial MRI studies. One case evolved to AML, two developed megaloblastic foci, and one remains hypoplastic at 19 months. This study suggests that MRI is able to detect early clonal disease in patients with AA. and can distinguish AA from hypoplastic marrow has been reviewed.I8-" The normal age-related distribution of hematopoietic and fatty and hematopoietic hyperplasiaL8-20 are readily observed. MRI has been used to study AA,24-3' MDS," acute and chronic leukemias,24-27,29,31.33. 34 and myeloproliferative disorSevere AA is expected to have a typical appearance in MRI, due to fatty replacement of the marrow. This has been observed in some st~dies~'.~' but not other^,'^.^^ and in one series five of eight patients with AA had inhomogeneous foci3' In this report, we establish the spectrum of findings in MRI studies of the bone marrow in 12 patients with AA and MDS. We then describe 12 patients with primary or secondary hypoplasia and evidence for cellular foci in the MRI who concurrently or subsequently were found to have clonal marrow disease.
ders. 18,20.31,34-36 MATERIALS AND 
METHODS
Patients were recruited from a tertiary care hematology practice. Signed informed consent was obtained under Institutional Review Board guidelines. Severe AA was defined according to criteria of the IAASG1-less than 25% normal cellularity in marrow biopsy and two or three of the following: anemia with reticulocytes less than 1%, corrected for hematocrit (less than approximately 50 x 10yIL), granulocytes less than 0.5 x 109/L, and platelets less than 20 x 109/L. MDS with normocellular or hypercellular marrow was defined according to the FAB classification*: RA, refractory anemia; RARS, refractory anemia with ringed sideroblasts; RAEB, refractory anemia with excess blasts; CMML, chronic myelomonocytic leukemia; RAEBT, MDS in transformation to leukemia. The term hypoplastic MDS was applied to patients with morphologic or cytogenetic evidence for MDS but less than 20% cellularity in the marrow.
Patients had bone marrow aspirates and biopsies from the posterior superior iliac crest within 6 weeks of the MRI study, and complete blood counts within 3 weeks of the MRI study. Marrow cellularity was determined from the biopsy and estimated to the nearest 10%. Cytogenetic analysis of cells in the bone marrow was performed using both Q-banding and G-banding techniques.
Peripheral blood counts in these patients were stable or worsening, so that hematopoietic response to therapy was not a factor in this study.
Two heavily transfused patients with hemosiderosis, which has a magnetic susceptibility effect causing a marked signal loss within the bone marrow, liver, and spleen in MRI,'7 were excluded from this report. MRI was performed using spin-echo radiofrequency pulse sequences with the whole-body transmitter/receiver coil in a 1.5 Tesla Siemens (Iselin, NJ) instrument. Sagittal and coronal T,-weighted images of the spine, sacrum, pelvis, hips, and femurs were obtained in contiguous 7-to 8-mm slices in a 256 x 256 matrix with T R = 550 millisecond, TE = 22 ms, and acquisitions = 2. Presaturation pulses were used to reduce motion artifact from movement in the anterior chest and abdomen. In these T,-weighted images tissues with a short proton T,, such as fatty tissue, have high signal and appear bright, while those with a long T,, such as cellular marrow, have low signal and appear dark. Short time-interval inversion recovery (STIR)3K sagittal images of the spine and coronal images of the femurs were obtained in 7-mm slices with a 3.5-mm gap in a 256 x 256 matrix with T R = 1,500 ms, T E = 22 ms. and TI = 130 ms. The TI of 130 ms was selected because it resulted in the most complete elimination of the signal from fatty tissues. In MRIs were reviewed by two observers, and the general pattern in the spine, pelvis, and femurs was categorized as: (1) fatty, (2) fatty with small cellular nodules, (3) inhomogeneously cellular, and (4) diffusely cellular. Table 1 . Three had AA, two hypocellular MDS, and seven cellular or hypercellular MDS. These patients serve as a reference set. Figure 1A shows the appearance of a fatty marrow in a patient with aplastic anemia: abnormally bright signal in the T,-weighted image. This image, while clearly fatty, is somewhat inhomogeneous. The fact that inhomogeneity is not caused by cellular foci is shown by the total absence of signal in the marrow in the STIR image (Fig 1B) .
RESULTS

Spectrum of marrow MRIpattems in patients with
Three abnormal marrow patterns in MRI were observed in patients with MDS: (1) multiple small nodules, often superimposed on a fatty background (Fig 2A) ; (2) inhomogeneously cellular lesions ( Fig 2B) ; and (3) relatively diffuse cellularity (Fig 2C) . That the inhomogeneous pattern of Fig 2B consists of fatty and cellular regions is shown in the STIR image in Figure 2D .
In the patients in Table 1 , the marrow biopsy results were representative of the remainder of the marrow assessed with MPI. Hypocellular marrows were fatty or fatty with small nodules in MRI; normocellular or hypercellular aspirate marrows were inhomogeneously or diffusely cellular in MRI.
Eight patients with hypocellular marrow biopsies were referred to us with clinical diagnoses of AA, but had abnormalities in MRI of the marrow not compatible with AA alone but suggestive of MDS. The clinical and MRI features of these patients (nos. 13 through 20) are summarized in Table 2 .
MR images from patient no. 14 show a multifocal inhomogeneous pattern with an admixture of fatty regions (Fig 3) . Additional support for a diagnosis of MDS in this patient is provided by the finding of a trisomy 8 cytogenetic abnormality. None of these patients had more than 5% blasts in their bone marrow at the time of, or just preceding, the MRI study, but adjunctive evidence for MDS was found concurrently or during subsequent follow-up in seven of these eight patients. Two had cytogenetic abnormalities, one had megaloblastic foci, two had blasts detected in the buRy coat, and one evolved to AML (M7). One (patient no. 20) had hypoplastic iliac crest biopsies but dysplastic and sideroblastic foci in a sternal aspirate. In the eighth (patient no. 17), who has only mild anemia and moderate leukocytopenia, the clinical diagnosis remains AA at 10 months follow-up, but the MR study clearly shows a predominantly cellular marrow.
In these patients with a diagnosis of AA and MRI evidence of inhomogeneous or diffuse cellularity (Table 2) , the marrow biopsies were not representative of the remainder of the marrow assessed with MRI.
Suspected clonal disease in previously treated lymphoma patients with pancytopenia. This group consists of four patients (nos. 21 through 24 in Table 3 ) who had previously received intensive treatment for lymphoma, and now had Detection of cellular foci in AA by MRI. For personal use only. on November 15, 2017. by guest www.bloodjournal.org From unexplained pancytopcnias and hypocellular marrow biopsies. The T,-weighted MR images generally showed a somewhat fatty background marrow pattern, but superimposed on this was a speckled pattcrn of small nodular lesions. The sequence of events in case no. 21 is shown in Fig 4. The specklcd pattcrn preccdcd by 2 months a diagnosis of secondary AML. In the coursc of serial studies in over 100 patients following bone marrow transplantation, this pattern has appeared in thrcc patients (nos. 22 through 24). Although this pattern can bc a manifestation of normal hematopoietic recovery," this was not the case in thcse patients because of the pcrsistcnt hypocellularity of their marrow biopsies, occurring at 15, 10, and 19 months after transplantation, rcspcctivcly. Therefore, we suspect that the spccklcd pattern, which is vcry similar to that observed in patients with cstablishcd hypoplastic MDS (Fig 2A) , indicates early clonal discasc. In fact, two of thcse patients have developed otherwise uncxplaincd megaloblastic foci in their marrow biopsics, and the third (no. 24) has progressivcly severe neutropenia with peripheral nucleated RBCs at 19 months after transplantation.
DISCUSSION
These results suggest a rolc for MRI as a problcm-solving tool in selected patients with hypoplastic marrow disorders. In particular, MRI appcars to bc able to distinguish aplastic anemia from hypoplastic MDS, and to providc evidence for clonal disease (MDS or AML) at an early stage.
MRI is complcmentary to the bone marrow biopsy in that, although it shows only the gross anatomy of the marrow, it can sample a large fraction of the active marrow in a single, noninvasive, clinical study. Abnormal marrow patterns in MRI are not specific. For example, the diffusely cellular pattern also occurs in acute and chronic leukemias, and the inhomogeneously cellular pattern also occurs in lymphoma and multiple myeloma.'" 2i i ' " Howevcr, oncc an abnormal pattern is detected in MRI, then MRI can be used in place of biopsies when serial studies are desired. The ability of MRI to distinguish patients with hypoplastic MDS from those with AA relics primarily on thc finding of multinodular or inhomogeneous foci superimposed on either a normal or a fatty background. It should be cmphasized that thc typical appearancc of fatty marrow in MRI-bright signal in T,-weighted images and no signal in STIR images-can be altered by the presence of hemosidcrosis. Thc typical fatty appearancc of AA can also be altered by effective treatment, in which foci of normal hcmatopoiesis appear.n.27.2x.'i' Therefore, intcrpretation of MRI must take into account the patient's transfusion history and any rcccnt treatments, ncithcr of which wcrc factors in thc patients presented here.
The MRI methods we uscd in this study permit imaging of a fairly largc area of marrow in a period of time (45 minutes) tolcratcd by virtually all patients. In our cxperience thc combination of TI-weightcd and STIR images are most useful. Thc sensitivity of MRI to marrow disease might be improvcd by a quantitative scparation of fat and water signals, madc possible by thc chcmical shift diffcr- 
